LMAT R&D to Revenue
Lemaitre Vascular Inc · R&D to Revenue
LMAT R&D to Revenue
Latest reported5.66%period ending
LMAT FY R&D/Revenue (6.87% → 5.66%)
Latest values, visible window
High-resolution chart · PNG
LMAT r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 5.6646% | |
| 7.1181% | |
| 8.7687% | |
| 8.2239% | |
| 7.6419% | |
| 7.8065% | |
| 7.9125% | |
| 7.7647% | |
| 6.579% | |
| 6.8883% | |
| 6.9928% | |
| 6.5699% | |
| 8.1225% | |
| 8.9751% | |
| 7.671% | |
| 9.7895% | |
| 11.6092% | |
| 10.936% | |
| 11.0771% | |
| 9.5327% | |
| 9.8122% | |
| 8.0969% | |
| 0% | |
| 7.458% | |
| 6.8685% |